Clinical Trial

A Study Evaluating the Diagnostic Performance of OCS in the Differential Diagnosis of Endometriosis vs. Endometriosis-Associated Ovarian Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 19, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospectively enroll patients with endometriosis and EAOC who complete the routine diagnostic and treatment process and consent to surgical intervention for OCS testing. Using postoperative ovarian pathological diagnosis as the gold standard, evaluate the clinical diagnostic performance of exosome detection in differentiating between endometriosis and EAOC.
Trial Details
NCT Number NCT07029659
Lead Sponsor Peking Union Medical College Hospital
Conditions Endometriosis, Endometriosis-Associated Ovarian Carcinoma
Enrollment 336 participants
Start Date 2025-07-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-19